Cancer Pain ManagementJones and Bartlett Publishers, 1995 - 380 pages Cancer Pain Management, Second Edition will substantially advance pain education. The unique combination of authors -- an educator, a leading practitioner and administrator, and a research scientist -- provides comprehensive, authoritative coverage in addressing this important aspect of cancer care. The contributors, acknowledged experts in their areas, address a wide scope of issues. Educating health care providers to better assess and manage pain and improve patientsrsquo; and familiesrsquo; coping strategies are primary goals of this book. Developing research-based clinical guidelines and increasing funding for research is also covered. Ethical issues surrounding pain management and health policy implications are also explored. |
From inside the book
Results 1-3 of 92
Page 135
PHARMACOLOGY OF SPINAL DRUG DELIVERY As new information is available regarding pain processes , new agents can be ... the drug can eventually enter into the systemic circulation or cross the dura to the CSF.7 The distribution of drugs ...
PHARMACOLOGY OF SPINAL DRUG DELIVERY As new information is available regarding pain processes , new agents can be ... the drug can eventually enter into the systemic circulation or cross the dura to the CSF.7 The distribution of drugs ...
Page 366
CSA includes provisions for preventing the diversion of controlled substances to illicit uses, but it also aims to prevent interference with the availability of FDA-approved drugs for legitimate purposes. Controlled substances include ...
CSA includes provisions for preventing the diversion of controlled substances to illicit uses, but it also aims to prevent interference with the availability of FDA-approved drugs for legitimate purposes. Controlled substances include ...
Page 366
Schedule III drugs are those with abuse potential and dependence liability less than schedule II but greater than schedules IV , V , and VI drugs . Examples are codeine , hydrocodone , and opium in combination with nonopioid drugs .
Schedule III drugs are those with abuse potential and dependence liability less than schedule II but greater than schedules IV , V , and VI drugs . Examples are codeine , hydrocodone , and opium in combination with nonopioid drugs .
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Common terms and phrases
action activity acute administration American analgesic anxiety approach appropriate assessment associated behavioral cancer pain cancer patients caregivers cause cells changes Chapter child chronic clinical cognitive communication considered continuous cultural described develop differences dimension discussed dose drugs effects elderly epidural et al ethical evaluation example experience factors Ferrell fibers Figure findings groups guidelines half-life identified important improve increase indicated individual influence intensity interventions issues knowledge less meaning measures medication ment methods morphine nerve NIMs Nurs nurses Oncology opioid oral pain management pain relief perception person physical position potential practice prayer present professional receiving referred regarding relaxation reported requires response result role scale selected setting severe specific spinal spiritual strategies suffering suggested symptoms Table therapy tients tion tolerance treat treatment understanding unit values York
References to this book
Bibliographic information
| Title | Cancer Pain Management Jones and Bartlett series in oncology Nursing Series |
| Authors | Deborah B. McGuire, Connie Henke Yarbro, Betty Ferrell |
| Editors | Deborah B. McGuire, Connie Henke Yarbro, Betty Ferrell |
| Edition | 2, illustrated |
| Publisher | Jones and Bartlett Publishers, 1995 |
| Original from | the University of Michigan |
| Digitized | 1 Aug 2008 |
| ISBN | 0867207256, 9780867207255 |
| Length | 380 pages |
| Export Citation | BiBTeX EndNote RefMan |